Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.50
Bid: 1,604.00
Ask: 1,604.50
Change: 4.50 (0.28%)
Spread: 0.50 (0.031%)
Open: 1,600.50
High: 1,612.50
Low: 1,591.00
Prev. Close: 1,595.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Bernstein Raises Tesco And Cuts Morrisons

Mon, 08th Sep 2014 08:35

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BERNSTEIN RAISES TESCO TO 'MARKET-PERFORM' ('UNDERPERFORM') - PRICE TARGET 235 PENCE
----------
BERNSTEIN CUTS MORRISON TO 'UNDERPERFORM' ('MARKET-PERFORM') - PRICE TARGET 140 (180) PENCE
----------
CS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1400 (1475) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES BARCLAYS PRICE TARGET TO 300 (285) PENCE - 'BUY'
----------
JPMORGAN RAISES BARRATT DEVELOPMENTS TO 'OVERWEIGHT.' ('NEUTRAL') - PT 460 (440) PENCE
----------
JPMORGAN RAISES INTU PROPERTIES PRICE TARGET TO 340 (305) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES PERSIMMON PRICE TARGET TO 1650 (1570) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS DIAGEO PRICE TARGET TO 1730 (1760) PENCE - 'UNDERWEIGHT'
----------
HSBC CUTS HARGREAVES LANSDOWN PRICE TARGET TO 850 (950) PENCE - 'UNDERWEIGHT'
----------
CITIGROUP RAISES RECKITT BENCKISER PRICE TARGET TO 6000 (5700) PENCE - 'BUY'
----------
FTSE 250
----------
JEFFERIES RAISES BODYCOTE PRICE TARGET TO 835 (825) PENCE - 'BUY'
----------
LIBERUM RAISES CARILLION PRICE TARGET TO 440 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS PREMIER OIL PRICE TARGET TO 420 (495) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS AFREN PRICE TARGET TO 130 (175) PENCE - 'HOLD'
----------
JPMORGAN RAISES BELLWAY PRICE TARGET TO 2100 (2000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BERKELEY GROUP PRICE TARGET TO 2900 (2800) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BOVIS HOMES PRICE TARGET TO 1000 (950) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS REDROW PRICE TARGET TO 330 (365) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES JLT GROUP PRICE TARGET TO 1260 (1180) PENCE - 'OVERWEIGHT'
----------
CITIGROUP CUTS SYNERGY HEALTH TO 'NEUTRAL' ('BUY') - TARGET 1600 (1145) PENCE
----------
NUMIS RAISES JUPITER FUND TO 'BUY' ('ADD') - TARGET 480 (475) PENCE
----------
NUMIS CUTS KAZAKHMYS PRICE TARGET TO 280 (290) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
DEUTSCHE BANK CUTS SALAMANDER ENERGY TO 'HOLD' ('BUY') - TARGET 125 (185) PENCE
----------
JPMORGAN CUTS LONDON MINING TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 27 (100) PENCE
----------
CANACCORD CUTS CHARLES STANLEY GROUP PRICE TARGET TO 385 (480) PENCE - 'BUY'
----------
CITIGROUP CUTS LAMPRELL TO 'NEUTRAL' ('BUY') - TARGET 177 PENCE
----------
NUMIS CUTS PETROPAVLOVSK PRICE TARGET TO 30 (60) PENCE - 'SELL'
----------
NUMIS RAISES RIVER & MERCANTILE PRICE TARGET TO 238 (235) PENCE - 'ADD'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.